NL-OMON56487
Not yet recruiting
Not Applicable
Assessment of clinical neurophysiological biomarkers for the differentiation of neurodegenerative disease versus non-neurological disorder in patients with mild cognitive impairment. - Clinical neurophysiological biomarkers in mild cognitive impairment.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cognitive disorders
- Sponsor
- Centre for Human Drug Research
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or female subject of \>\= 45 years of age at screening.
- •2\. Cognitive disorders defined as mild cognitive impairment diagnosed by a
- •neurologist, suspected due to neurodegenerative disease or non\-neurological
- •disorder (e.g. psychiatric disorders).
- •3\. Willing and able to voluntary sign the informed consent form (ICF).
- •4\. Willing and able to communicate with the investigator and site staff and to
- •comply with the study requirements and visits.
Exclusion Criteria
- •1\. Clinically significant findings as determined by medical history taking,
- •physical examination, ECG and vital signs, which, in the opinion of the
- •Investigator, does not allow study participation.
- •2\. Any previously diagnosed dementia or other neurodegenerative disease at or
- •prior to screening
- •3\. Any current, clinically significant, known neurological cause of cognitive
- •disorders at or prior to screening.
- •4\. Inability to willfully sign the informed consent document, supported by an
- •MMSE \< 24 at screening. Exceptionally, patients with an MMSE \< 24 can be
- •included only if the rationale is clearly documented by the investigator (i.e.,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Assessing the functional outcome of the spinal tumour surgeryCTRI/2024/02/063352ational Institute of Mental Health and Neuro Sciences NIMHANS
Not yet recruiting
Not Applicable
Multiple neurophysiologic biomarkers evaluated the pulmonary function of ALS.amyotrophic lateral sclerosis(ALS)JPRN-UMIN000042222ara Medical University20
Active, not recruiting
Phase 1
Assessment of Neurobiological Markers using different methodologies for Psychiatric DisordersEUCTR2011-004860-31-ATMedical University of Vienna
Recruiting
Not Applicable
Investigation of neurophysiological marker in internet game addictioMental and behavioral disordersKCT0001849Seoul Metropolitan Government Seoul National University Boramae Medical Center750
Completed
Not Applicable
Evaluation of clinical, neurophysiological and imaging parameter to detect and characterize chronic central neuropathic pain after spinal cord injuryDRKS00006779Klinik für Paraplegiologie,Universitätsklinikum Heidelberg27